Literature DB >> 11978568

Sjögren-Larsson syndrome: biochemical defects and follow up in three cases.

Mariam Patrícia Auada1, Maria Beatriz Puzzi Taube, Edgard F Collares, Ana Maria Uthida Tanaka, Maria Letícia Cintra.   

Abstract

Sjögren-Larsson syndrome is a rare disorder that consists of congenital ichthyosis and neurological symptoms due to an enzymatic defect of fatty aldehyde dehydrogenase in the fatty alcohol cycle. We report three cases of Sjögren-Larsson syndrome in which the primary biochemical defect was established in two patients (patient 2: 175 pmol/min/mg; patient 3: 103 pmol/min/mg protein enzimatic activity in fibroblasts in skin, while normal controls were 8,860 +/- 1,624, n: 22 ). A dietary program was proposed: reduced total fatty intake at 30% of total calories, n-3 and n-6 acids (canola oil) as well as unsaturated fatty acids (Milupan milk). Topical keratolytic agents were used too. Good clinical course was observed in one of the patients in whom dietary intervention was started in early infancy. In the other two patients, who started the therapy later (five and three years old), cutaneous symptoms were improved after treatment.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11978568

Source DB:  PubMed          Journal:  Eur J Dermatol        ISSN: 1167-1122            Impact factor:   3.328


  4 in total

1.  Sjögren-Larsson syndrome in Brazil is caused by a common c.1108-1G-->C splice-site mutation in the ALDH3A2 gene.

Authors:  M P Auada; M B Puzzi; M L Cintra; C E Steiner; F Alexandrino; E L Sartorato; T S Aguiar; R D Azulay; G Carney; W B Rizzo
Journal:  Br J Dermatol       Date:  2006-04       Impact factor: 9.302

2.  Texture analysis of the epidermis based on fast Fourier transformation in Sjögren-Larsson syndrome.

Authors:  Mariam P Auada; Randall L Adam; Neucimar J Leite; Maria B Puzzi; Maria L Cintra; William B Rizzo; Konradin Metze
Journal:  Anal Quant Cytol Histol       Date:  2006-08       Impact factor: 0.302

3.  Genetics and prospective therapeutic targets for Sjögren-Larsson Syndrome.

Authors:  William B Rizzo
Journal:  Expert Opin Orphan Drugs       Date:  2016-03-10       Impact factor: 0.694

Review 4.  Sjogren-Larsson Syndrome: Mechanisms and Management.

Authors:  Parayil Sankaran Bindu
Journal:  Appl Clin Genet       Date:  2020-01-07
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.